Association	O
of	O
C-	B:C1413716
Reactive	I:C1413716
Protein	I:C1413716
(	I:C1413716
rs1205	I:C1413716
)	I:C1413716
Gene	O
Polymorphism	O
with	O
Susceptibility	B:C0012655
to	O
Psoriasis	B:C0033860
in	O
South	B:C0337946
Indian	I:C0337946
Tamils	I:C0337946
.	O

Psoriasis	B:C0033860
is	O
a	O
multi-	O
factorial	O
heritable	O
T	B:C0242632
-	I:C0242632
helper	I:C0242632
Th	I:C0242632
-	I:C0242632
1	I:C0242632
/	O
Th	B:C2936411
-	I:C2936411
17	I:C2936411
mediated	O
inflammatory	B:C1290884
disease	I:C1290884
,	O
affecting	O
the	O
skin	B:C1123023
.	O

It	O
is	O
associated	O
with	O
co-morbidities	O
such	O
as	O
Cardiovascular	B:C0007222
Disease	I:C0007222
(	O
Cardiovascular	B:C0007222
Disease	I:C0007222
)	O
.	O

C-	B:C0006560
Reactive	I:C0006560
Protein	I:C0006560
(	O
C	B:C0006560
-	I:C0006560
Reactive	I:C0006560
Protein	I:C0006560
)	O
is	O
a	O
good	O
inflammatory	O
marker	B:C0005516
.	O

CRP	B:C1413716
rs1205	I:C1413716
polymorphism	O
is	O
associated	O
with	O
circulating	O
plasma	B:C1306826
CRP	I:C1306826
levels	I:C1306826
.	O

Although	O
there	O
is	O
association	O
between	O
the	O
rs1205	B:C0752046
Single	I:C0752046
Nucleotide	I:C0752046
Polymorphism	I:C0752046
(	I:C0752046
SNP	I:C0752046
)	I:C0752046
and	O
Cardiovascular	B:C0007222
Disease	I:C0007222
,	O
there	O
are	O
no	O
prior	O
reports	O
regarding	O
the	O
association	O
of	O
C	B:C0006560
-	I:C0006560
Reactive	I:C0006560
Protein	I:C0006560
rs1205	B:C0752046
SNP	I:C0752046
with	O
psoriasis	B:C0033860
susceptibility	B:C0012655
.	O

To	O
study	B:C2603343
the	O
association	O
of	O
the	O
genetic	B:C0678941
variant	I:C0678941
rs1205	B:C1413716
in	O
the	O
CRP	B:C1413716
gene	I:C1413716
with	O
susceptibility	B:C0012655
to	I:C0012655
the	I:C0012655
disease	I:C0012655
and	O
protein	B:C0428479
levels	I:C0428479
in	O
South	B:C0337946
Indian	I:C0337946
Tamils	I:C0337946
with	O
psoriasis	B:C0033860
.	O

In	O
this	O
case	B:C0007328
-	I:C0007328
control	I:C0007328
genetic	B:C2827447
study	I:C2827447
,	O
300	O
cases	O
of	O
psoriasis	B:C0033860
and	O
300	O
age	O
and	O
gender	O
matched	O
controls	O
were	O
genotyped	O
for	O
CRP	B:C1413716
SNP	I:C1413716
rs1205	I:C1413716
using	O
Taq	B:C0005507
Man	I:C0005507
5	I:C0005507
'	I:C0005507
allele	I:C0005507
discrimination	I:C0005507
assay	I:C0005507
at	O
Jawaharlal	B:C0018696
Institute	I:C0018696
of	I:C0018696
Postgraduate	I:C0018696
Medical	I:C0018696
Education	I:C0018696
and	I:C0018696
Research	I:C0018696
,	O
Puducherry	O
,	O
India	B:C0021201
from	O
February	O
2014	O
to	O
January	O
2016	O
.	O

Plasma	B:C0032105
high	O
sensitivity	O
(	O
hs	O
)	O
-	O
CRP	B:C0428528
levels	I:C0428528
were	O
estimated	O
by	O
ELISA	B:C0014441
.	O

CRP	B:C1413716
genetic	I:C1413716
variation	I:C1413716
rs1205	I:C1413716
was	O
not	O
associated	O
with	O
psoriasis	B:C0033860
risk	O
in	O
our	O
South	B:C0337946
Indian	I:C0337946
Tamil	I:C0337946
population	I:C0337946
.	O

However	O
,	O
the	O
circulating	O
levels	O
of	O
hs	O
-	O
C	B:C0006560
-	I:C0006560
Reactive	I:C0006560
Protein	I:C0006560
was	O
significantly	O
higher	O
in	O
patients	O
with	O
psoriasis	B:C0033860
,	O
as	O
compared	O
with	O
controls	O
(	O
p	O
<	O
0.0001	O
)	O
and	O
the	O
protein	B:C0428479
levels	I:C0428479
were	O
significantly	O
associated	O
with	O
disease	O
severity	O
,	O
as	O
assessed	O
by	O
PASI	O
scoring	O
.	O

No	B:C1513916
genotype	O
was	O
found	O
significantly	O
associated	O
with	O
PASI	O
or	O
CRP	B:C0428528
levels	I:C0428528
.	O

Our	O
results	O
suggest	O
that	O
plasma	B:C1306826
CRP	I:C1306826
levels	I:C1306826
are	O
higher	O
in	O
patients	O
with	O
psoriasis	B:C0033860
and	O
correlate	O
with	O
disease	O
severity	O
,	O
whilst	O
CRP	B:C1413716
rs1205	I:C1413716
is	O
not	O
associated	O
with	O
susceptibility	B:C0012655
to	O
psoriasis	B:C0033860
in	O
South	B:C0337946
Indian	I:C0337946
Tamils	I:C0337946
.	O

